Results 211 to 220 of about 5,702,760 (334)
Longitudinal insights into the industrial IoT-green intellectual capital Nexus in the post-COVID era using SEM‑ANN approach. [PDF]
Cao Y, Xinwen L.
europepmc +1 more source
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa +14 more
wiley +1 more source
CT and MRI imaging of mass in the carotid space: a pictorial review. [PDF]
Chen Z, Wei Y, Lu C.
europepmc +1 more source
Multicolour time series photometry of the variable star 1SWASP J234401.81−212229.1
C. Koen
semanticscholar +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
External Validation of the International Staging Collaboration for Cancer of the Prostate (STAR-CAP) Prognostic System in Patients Managed with Active Surveillance. [PDF]
Berlin A +7 more
europepmc +1 more source
The MACHO Project LMC Variable Star Inventory: Classical Cepheids and AGB Variables [PDF]
D. R. Alves +20 more
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source

